Luspatercept (ACE-536) increases hemoglobin and decreases transfusion burden and liver iron concentration in adults with beta-thalassemia: Preliminary results from a phase 2 study

Authors
Category Primary study
JournalHaematologica
Year 2015
This article has no abstract
Epistemonikos ID: 2da6235697009d0c22955d59f58e59623e8e1fe0
First added on: Feb 07, 2025